G1 Therapeutics (NASDAQ:GTHX) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
G1 Therapeutics reported in-line EPS of $-1.0 versus an estimate of $-1.0, which did not surprise analysts.
Revenue was up $21,741,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03, which was followed by a 3.35% drop in the share price the next day.
Here's a look at G1 Therapeutics's past performance:
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
